je.st
news
FDA accepts Mylan's ANDA filing for generic Copaxone 40 mg/mL
2014-08-29 14:50:24| Biotech - Topix.net
Mylan Inc. today announced that its abbreviated new drug application for a three times per week Glatiramer Acetate Injection 40 mg/mL has been accepted for filing by the U.S. Food and Drug Administration .
Tags: filing
generic
accepts
anda
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||